Patti E Gravitt
Biographic Data
| ID | 7595839 |
|---|---|
| NAME | Patti E Gravitt |
| GIVEN NAMES | Patti E |
| FAMILY NAME | Gravitt |
| SIGNATURE | GRAVITT P E |
| AFFILIATIONS | University of Maryland, Baltimore |
| ORCID | 0000-0002-3007-3425 |
| VERIFIED | Yes |
| TOTAL WORKS | 7 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 7 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2008 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Factors Associated With Parental Willingness to Vaccinate Daughters Against Human Papillomavirus in Peru
Cervical cancer remains a leading cause of mortality among women worldwide, particularly in low- and middle-income countries, yet human papillomavirus (HPV) vaccination—the most effective method of prevention—faces variable uptake and acceptance. This study addresses the problem of suboptimal HPV vaccination by examining the factors associated with parental consent for HPV vaccination of adolescent girls in two distinct Peruvian cities, the capit…
A realist evaluation of a novel cervical cancer prevention strategy in Iquitos, Peru
Proyecto Precancer is an implementation science and systems-thinking project with the objective of facilitating the adoption of a new screen-and-treat intervention for cervical cancer prevention in Iquitos in the Peruvian Amazon basin. This intervention introduced human papillomavirus molecular testing and shifted treatment from the tertiary level to the primary level through visual assessment for treatment and thermal ablation for those eligible…
Assessing the global implications of the Covid-19 pandemic on the cervical cancer elimination initiative
The COVID-19 pandemic disrupted many public health programs; understanding these disruptions is critical for directing future resources. In a project studying the implementation of human papillomavirus (HPV) testing-based cervical cancer screening, we queried about the impact of the pandemic on screening programs globally. In consultation with World Health Organization’s Regional Advisors, program managers, government officials, and clinicians in…
Challenges associated with follow-up care after implementation of an HPV screen-and-treat program with ablative therapy for cervical cancer prevention
This study highlights the barriers to follow-up after implementation of a primary-level HPV-based screen-and-treat approach. While some barriers that have previously been associated with loss to follow-up were not as prominently observed in this study (e.g., financial), we emphasize the need for screen-and-treat programs to focus on strategies that can address incomplete registry systems, structural challenges in results delivery, cognitive barri…
Easy women get it”
Cervical cancer early detection and treatment programs in limited resource settings must address stigma entrenched throughout the entire healthcare system and community in order to sustainably and successfully implement and scale-up new programs. Interventions to tackle this stigma can incorporate messages about HPV infections and latency to lessen the focus on the influence of sexual behavior on HPV acquisition, and instead, promote screening an…
Acceptability of HPV Vaccine Implementation Among Parents in India
Due to high cervical cancer rates and limited research on human papillomavirus (HPV) vaccine acceptability in India, the research team examined parental attitudes toward HPV vaccines. Thirty-six interviews with parents were conducted to assess sexually transmitted infection (STI)-related knowledge and HPV-specific vaccine awareness and acceptability. Despite limited knowledge, parents had positive views toward HPV vaccines. Common barriers includ…
Baseline assessment of prevalence and geographical distribution of HPV types in Chile using self-collected vaginal samples
Self-obtained vaginal sampling is adequate for monitoring HPV in the community, for identifying high-risk areas, and for surveying the long term impact of interventions
No prominent works on this page.
Baseline assessment of prevalence and geographical distribution of HPV types in Chile using self-collected vaginal samples
Self-obtained vaginal sampling is adequate for monitoring HPV in the community, for identifying high-risk areas, and for surveying the long term impact of interventions
Acceptability of HPV Vaccine Implementation Among Parents in India
Due to high cervical cancer rates and limited research on human papillomavirus (HPV) vaccine acceptability in India, the research team examined parental attitudes toward HPV vaccines. Thirty-six interviews with parents were conducted to assess sexually transmitted infection (STI)-related knowledge and HPV-specific vaccine awareness and acceptability. Despite limited knowledge, parents had positive views toward HPV vaccines. Common barriers includ…
Easy women get it”
Cervical cancer early detection and treatment programs in limited resource settings must address stigma entrenched throughout the entire healthcare system and community in order to sustainably and successfully implement and scale-up new programs. Interventions to tackle this stigma can incorporate messages about HPV infections and latency to lessen the focus on the influence of sexual behavior on HPV acquisition, and instead, promote screening an…
Challenges associated with follow-up care after implementation of an HPV screen-and-treat program with ablative therapy for cervical cancer prevention
This study highlights the barriers to follow-up after implementation of a primary-level HPV-based screen-and-treat approach. While some barriers that have previously been associated with loss to follow-up were not as prominently observed in this study (e.g., financial), we emphasize the need for screen-and-treat programs to focus on strategies that can address incomplete registry systems, structural challenges in results delivery, cognitive barri…
A realist evaluation of a novel cervical cancer prevention strategy in Iquitos, Peru
Proyecto Precancer is an implementation science and systems-thinking project with the objective of facilitating the adoption of a new screen-and-treat intervention for cervical cancer prevention in Iquitos in the Peruvian Amazon basin. This intervention introduced human papillomavirus molecular testing and shifted treatment from the tertiary level to the primary level through visual assessment for treatment and thermal ablation for those eligible…
Assessing the global implications of the Covid-19 pandemic on the cervical cancer elimination initiative
The COVID-19 pandemic disrupted many public health programs; understanding these disruptions is critical for directing future resources. In a project studying the implementation of human papillomavirus (HPV) testing-based cervical cancer screening, we queried about the impact of the pandemic on screening programs globally. In consultation with World Health Organization’s Regional Advisors, program managers, government officials, and clinicians in…
Factors Associated With Parental Willingness to Vaccinate Daughters Against Human Papillomavirus in Peru
Cervical cancer remains a leading cause of mortality among women worldwide, particularly in low- and middle-income countries, yet human papillomavirus (HPV) vaccination—the most effective method of prevention—faces variable uptake and acceptance. This study addresses the problem of suboptimal HPV vaccination by examining the factors associated with parental consent for HPV vaccination of adolescent girls in two distinct Peruvian cities, the capit…
Cervical cancer (6 works) · Cervical Cancer and HPV Research (6 works) · Public health (6 works) · Medicine (5 works) · Cancer (4 works) · Biostatistics (3 works) · Family medicine (3 works) · Global Cancer Incidence and Screening (3 works) · Health care (3 works) · Internal Medicine (3 works)